Core Insights - Privia Health reported revenue of $437.92 million for the quarter ended September 2024, reflecting a 5% increase year-over-year and a surprise of +5.67% over the Zacks Consensus Estimate of $414.44 million [1] - The company's EPS was $0.03, down from $0.05 in the same quarter last year, resulting in an EPS surprise of -50.00% compared to the consensus estimate of $0.06 [1] Financial Performance Metrics - Practice Collections reached $739.90 million, exceeding the average estimate of $716.69 million from eight analysts [3] - Care Margin was reported at $101.40 million, slightly above the average estimate of $99.80 million based on seven analysts [3] - Platform Contribution amounted to $50.30 million, surpassing the average estimate of $47.22 million from seven analysts [3] - Implemented Providers totaled 4,642, compared to the average estimate of 4,607 from three analysts [3] - Attributed Lives stood at 1.25 million, exceeding the average estimate of 1.18 million from three analysts [3] Stock Performance - Privia Health's shares have returned +25.8% over the past month, significantly outperforming the Zacks S&P 500 composite's +3.2% change [4] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [4]
Compared to Estimates, Privia Health (PRVA) Q3 Earnings: A Look at Key Metrics